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Argentina
The mammalian circadian system is controlled by a central oscillator located in the
suprachiasmatic nuclei (SCN) of the hypothalamus, in which glia appears to play a
prominent role. Gliomas originate from glial cells and are the primary brain tumors with the
highest incidence and mortality. Optic pathway/hypothalamic gliomas account for 4–7%
of all pediatric intracranial tumors. Given the anatomical location, which compromises
both the circadian pacemaker and its photic input pathway, we decided to study whether
the presence of gliomas in the hypothalamic region could alter circadian behavioral
outputs. Athymic nude mice implanted with LN229 human glioma cells showed an
increase in the endogenous period of the circadian clock, which was also less robust
in terms of sustaining the free running period throughout 2 weeks of screening. We also
found that implanted mice showed a slower resynchronization rate after an abrupt 6 h
advance of the light-dark (LD) cycle, advanced phase angle, and a decreased direct effect
of light in general activity (masking), indicating that hypothalamic tumors could also affect
photic sensitivity of the circadian clock. Our work suggests that hypothalamic gliomas
have a clear impact both on the endogenous pacemaking of the circadian system, as well
as on the photic synchronization of the clock. These findings strongly suggest that the
observation of altered circadian parameters in patients might be of relevance for glioma
diagnosis.
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INTRODUCTION
Gliomas, a type of tumor arising from glial cells, are the most common type of primary brain
tumors and are classified in four types (I-IV), according to their malignancy (Wen and Kesari,
2008). Patients suffering from type IV gliomas (also characterized as glioblastomas) account for
approximately 45% of all malignant CNS tumors, with a median survival of less than 15 months
(Ostrom et al., 2013; Lee, 2017). Among the common symptoms leading to glioma diagnosis,
neurological distress appears as one of the earliest reasons for consultation (Weller et al., 2017).
Previous reports have shown that two of the most common factors affecting the life quality of
glioma patients are sleep disturbances and fatigue (Rooney et al., 2013). Brain and CNS tumors
are the most common form of solid tumors in children and among them, anatomical location of
hypothalamic and optic tract tumors represent 5–7% of all cases (Massimi et al., 2007; Ostrom et al.,
2013). These gliomas tend to be nonaggressive low-grade tumors, with pilocytic astrocytoma being
the most common pathology in young adults. However, chiasmatic-hypothalamic masses in adults
are challenging to diagnose and tend to have an aggressive clinical course (Raelson and Chiang,
2015).
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The hypothalamus also hosts the mammalian circadian clock,
led by a master oscillator that resides in the suprachiasmatic
nuclei (SCN), which receives photic entrainment cues through a
retinohypothalamic tract. This clock is able to sustain oscillations
with a period close to 24-h, even in the absence of external
stimulation, and it can adapt to changes in the light-dark cycle
through a specific synchronization pathway (Golombek and
Rosenstein, 2010). Several physiological and behavioral variables,
including hormone levels and neurological functions, are
regulated by the circadian clock, which also plays a key role in the
regulation of sleep-wake cycles (Musiek and Holtzman, 2016).
Moreover, circadian disruption and misalignment between the
internal clock and the environmental cycles have been associated
with mood disorders and fatigue (Golombek et al., 2013;
Bedrosian and Nelson, 2017).
Within the SCN, glial cells are involved in circadian
timekeeping (Barca-Mayo et al., 2017; Brancaccio et al., 2017;
Tso et al., 2017) and synchronization mechanisms (Lavialle
et al., 2001; Becquet et al., 2008; Girardet et al., 2010; Duhart
et al., 2013b), and are also considered as mediators between
proinflammatory signals and the circadian pacemaker (Leone
et al., 2006; Duhart et al., 2013a). Among the mechanisms
proposed for glial modulation of the circadian pacemaker, the
regulation of glutamate levels by SCN astrocytes is of key
importance for the proper functioning of the clock (Beaulé et al.,
2009; Leone et al., 2015; Brancaccio et al., 2017). Noteworthy,
increased glutamate levels are characteristic in gliomas (reviewed
in Robert and Sontheimer, 2014), suggesting that a dysregulation
of proper glial function occurring in this malignant tissue may
impact on both timekeeping and synchronization mechanisms of
the clock. In addition, molecules involved in immune responses,
such as TNF-α, IL-1β, and CCL2 have been shown to affect
the master circadian oscillator (Nygård et al., 2009; Leone
et al., 2012; Duhart et al., 2016). Gliomas drastically alter
the microenvironment in which they develop, and molecules
involved in the immune response have been shown to have an
important role in tumor progression (Reviewed in Christofides
et al., 2015).
Considering the prevalence of sleep alterations and fatigue
as a common symptom of gliomas, the anatomical compromise
of the master clock and optic tract in hypothalamic gliomas,
and the alteration of molecules relevant for the circadian
pacemaker in the tumor microenvironment, we hypothesized
that this pathology could impact circadian timekeeping, and such
alterations could be a valuable tool at the time of diagnosis. In
the present work we analyzed the effects of hypothalamic gliomas
in the endogenous characteristics of the circadian clock and its
ability to synchronize to light. In mice bearing hypothalamic
gliomas we found alterations in the synchronization to light-dark
cycles, as well as a clear effect on the endogenous period and its
stability.
MATERIALS AND METHODS
Animals
Adult Foxn1(1/1) male mice were purchased from Universidad
Nacional de La Plata animal facilities (La Plata, Argentina),
and were housed individually in cages, supplied with water and
food ad libitum and kept under sterile air ventilation and 12:12
light-dark cycles (12 h of light, 12 h of darkness, LD). Animal
manipulations and experimental protocols performed in this
work were supervised and approved by the National University
of Quilmes Institutional Animal Care and Use Committee, in
accordance with the National Institutes of Health guide for the
care and use of laboratory animals. After tumor implantation,
animals were monitored daily in search for hunched or abnormal
posture, lack of grooming, weight loss exceeding 20% of body
weight, anorexia, or abnormal ambulation. The presence of any
of these findings was considered an endpoint and mice were
euthanized using a CO2 chamber.
Cell Lines
Human glioblastoma cell line LN-229 (ATCC: CRL-2611) was
cultured in DMEM medium (Gibco, Thermo Fisher Scientific)
supplemented with 10% fetal bovine serum (PAA, Germany),
glutamine and antibiotic-antimicotic (Gibco).
Tumor Implantation
Two month-old animals were deeply anesthetized with 2%
isofluorane and implanted with 200,000 glioma LN-229 cells in
1 µl of DMEM by stereotactic surgery. The injection was aimed
unilaterally to the suprachiasmatic nucleus of the hypothalamus
(coordinates from Bregma: +0.3mm from midline; −0.1mm
anterior-posterior; −5.3mm dorso-ventral). Control animals
were treated with a Sham surgery in which the same volume of
DMEM, without cells, was injected.
Behavioral Analyses
General activity of animals was continuously registered by
infrared sensors with a system designed in our laboratory.
Activity counts were collected every 5min. In LD conditions,
time is described as Zeitgeber Time (ZT): ZT0 refers to the time
of lights on and ZT12 refers to the time of lights off. In constant
darkness (DD) conditions, time is expressed as Circadian Time
(CT), with CT 12 referring to the time of activity onset.
Prior to tumor implantation, mice were synchronized to 12:12
LD cycles and kept under these conditions for 25 days. After
implantation, animals continued under LD 12:12 cycles for 18
days. Afterwards, animals were divided in two groups. One
group, aimed to study the effects on circadian synchronization,
was exposed to a 6-h advance in the LD cycle (experimental
Jet-lag) by advancing the light phase and shortening of the
dark phase. This group continued in LD conditions for 32
days, received a second 6-h advance in the LD cycle and
continued in LD until endpoint. The second group, aimed to
study the endogenous circadian parameters, was kept in DD
conditions until endpoint. After sacrifice, brains were collected
and processed for Hematoxilyn-Eosin (HE) staining.
Data Analysis
Circadian parameters were calculated with El Temps program
(Antoni Díez Nogueira, University of Barcelona). In DD
conditions, free-running endogenous period (τ ) was analyzed
using Sokolove-Bushell (SB) periodograms. For period stability,
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a wavelet-based analysis was performed on custom-made Matlab
(Mathworks) scripts. Heat maps referring to instant period were
generated for each activity pattern, assessing the variability of
endogenous period. Statistical significance for periods calculated
by wavelet analysis were performed as described in Torrence and
Compo (1998). A variability index (V)was defined by quantifying
the complexity of the histogram of the periods obtained from the
wavelet analysis by a Shannon entropy estimation (Masè et al.,
2005). We first obtained the instant periods from the wavelet
transform and chose a bin size for the histogram construction (in
this case we used twice the sample size). To compute the Shannon
entropy (SE) of the period distribution we used the following
formula:
SE = −
m∑
i=i
p (i) ln p (i)
Where m is the number of bins with non-zero probability and
p(i) is the probability of assuming the ith value (frequency of
occurrence of i in N observations). To relate the dispersion of the
period distribution with the stability of the system, the V index
was defined as follows:
V = 1−
SE
lnN
The V index ranges from 0, when the spreading of the period
is maximal, to 1, when the probability distribution have a single
period.
In addition, Non-Parametric Circadian Rhythm Analysis
(NPCRA) was performed to analyze the interdaily stability (IS
index), and intradaily variability (IV index) of locomotor activity
rhythms in constant darkness (Van Someren et al., 1999). The IS
index was defined as the most significant period value from the
chi-square periodogram, normalized for the number of data, and
can be calculated as the ratio between the variance around the
mean of the most significant period and the overall variance:
IS =
n
∑p
h=1 (x¯h − x¯)
2
p
∑n
i=1 (xi − x¯)
2
Where n is the total number of data, p is the number of data per
day (according to the period), x¯h are the hourly means, x¯ is the
mean of all data, and xi represents the individual data points. The
IS tends to zero with Gaussian Noise and 1 for a perfect coupling.
The IV index was calculated as the ratio of the mean square of the
difference between all the successive hours (first derivate) and the
same computation around the overall mean:
IV =
n
∑n
i=2 (xi − xi−1)
2
(n− 1)
∑n
i=1 (xi − x¯)
2
The IV value is zero for a perfect sinusoidal wave, and is around
2 for Noise (Gaussian Noise).
For subjective night duration (α), an hourly waveform was
generated for the average activity of 15 days in DD conditions,
and time was calculated as time length covered by the portion of
the curve surpassing the mean of activity baseline. Conversely,
subjective day duration (ρ) was calculated as the time length
where the curve was under the mean activity baseline. Activity
during α was calculated as the area under the curve during
subjective night phase, normalized to total activity.
In LD conditions, 3 stages of the experiment were analyzed:
Before-Implantation (BI), Post-Implantation (PI) and Post-
jetlag (P-JL). Each period was analyzed separately: BI was the
synchronization stage prior to glioma implantation, PI was
considered from 4 days after surgery until the phase shift of
the cycle, and P-JL stage corresponded to the days after the
animals had resynchronized to the new LD cycle, until the end
of experiment. Activity onset was calculated using individual
waveforms of mean activity as the time at which the activity curve
overpassed the mean baseline for more than 2 h. Phase angle
was defined as the difference between the time of lights off (ZT
12) and the time of activity onset, with positive values referring
to activity onset occurring before lights off. LD period was
calculated with SB periodograms. Diurnal activity was calculated
as the area under the curve that was below the mean activity
baseline of individual waveforms for each stage, normalized
to total mean activity. Resynchronization speed was calculated
as described in Kiessling et al. (2010). Briefly, PS50, which
describes the amount of time in days needed to achieve 50% of
the resynchronization after the Jet-lag shift, was calculated by
adjusting a sigmoid dose-response curve with variable slope to
the onset of locomotor activity time points for each group, with
the following equation:
y = Bottom+
(Top− Bottom)
1+ 10(logPS50−x) . HillSlope
Differences between the best-fit PS50 values were compared by
extra sum-of-squares F-test.
In addition, the difference between the phase of activity onset
in the last 10 days of LD cycles and the first 10 days in DD
conditions (1ψ) was analyzed with circular statistics by Rayleigh
tests. First, individual Rayleigh tests for LD and DD conditions
were applied for each data set using the onset of activity as a
phase (ψ) marker. For LD Rayleigh plots, a 24 h period was used,
and for DDRayleigh plots we applied the endogenous period. For
each animal, the average 1ψ LD−DD was calculated and used as
entry data for a group Rayleigh analysis, using a 24 h period.
Data is presented as Mean ± SEM. Statistical analysis was
performed with GraphPad Prism 6 program. P-values minor to
0.05 were considered as statistically significant.
RESULTS
Hypothalamic Glioma Model
In order to analyze the effects of hypothalamic gliomas on the
circadian clock, we performed a unilateral implantation of LN-
229 human glioblastoma cells in the region of the SCN. This
resulted in 100% implantation efficiency and a mean survival of
54 ± 4 days (n = 15). Although we did not find an identical
distribution of the tumors among different animals, all of them
showedmasses compromising the ipsilateral hypothalamus, optic
Frontiers in Physiology | www.frontiersin.org 3 October 2017 | Volume 8 | Article 864
Duhart et al. Circadian Rhythms and Glioma
chiasm and part of the third ventricle, as well as vascularization
of the tumor (Figure 1).
Effects of Tumor Implantation on
Endogenous Circadian Timekeeping
The ability of the circadian clock to sustain proper endogenous
timekeeping is fundamental in order to adjust an appropriate
phase relation of clock-controlled outputs to the environment.
To study the implications of hypothalamic gliomas on the
endogenous properties of the circadian clock, we analyzed
different circadian parameters under DD conditions, where
rhythmicity is sustained only by the circadian clock, independent
of environmental cues. Table 1 summarizes our findings in this
approach.
One of the most important parameters of the endogenous
circadian rhythm is the period at which the clock runs without
external cues. Animals implanted with hypothalamic gliomas
presented a small, albeit significant, alteration in the endogenous
period of the circadian clock, with larger τ values than sham
controls (Figure 2; 23.92 ± 0.06 h, n = 9 and 23.58 ± 0.07,
n = 6, for implanted and control animals, respectively; p < 0.01,
Student’s t-test).
Besides affecting the endogenous period, we hypothesized that
hypothalamic gliomas would alter the ability of the clock to
sustain robust and stable endogenous rhythms. This hypothesis
was assessed by analyzing activity consolidation during the
subjective night and the presence of a stable τ throughout
several days. We found no difference in the distribution of the
activity, identified as α and ρ, during DD conditions between
implanted and control animals (Table 1). However, examination
of instant periods across the whole temporal series by means
of wavelet analysis suggested that the endogenous period was
less stable in implanted mice (Figure 3). Although analysis of
τ variability through wavelet-based computations, using the V
index, did not show statistically significant differences, a more
stringent analysis through NPCRA demonstrated that implanted
animals presented less robust rhythms under DD conditions. We
calculated the IV index which is an indicator of the fragmentation
of the locomotor activity, describing the duration and repetition
of transition between rest and activity, and the IS index which
quantifies the invariability between the days, that is, the strength
of coupling of the activity to the τ that best describes the
rhythms. We found that animals implanted with hypothalamic
tumors showed weaker stability of the rhythm related to the
coupling to a specific τ , and higher fragmentation of the activity
pattern (Figure 3 and Table 1; for IS, P < 0.01; for IV P < 0.05;
Student’s t-test, n = 6 for controls, n = 9 for implanted
mice).
Effect of Tumor Implantation on
Synchronization to Light-Dark Cycles
Besides alteration of endogenous timekeeping, hypothalamic
gliomas might affect entrainment to environmental cues. In
order to study the effects of hypothalamic gliomas in the ability
of the circadian clock to synchronize to light-dark schedules,
we analyzed the characteristics of activity rhythms both at a
stable LD schedule and during resynchronization to an abrupt
shift in the LD schedule (i.e., Jet Lag). The results of this set
of experiments are summarized in Table 2. It should be noted
that since animals were subjected to a Jet Lag protocol, the
analysis was divided in three stages, before implantation (BI),
post-implantation (PI) and after Jet Lag protocol (P-JL). For the
P-JL stage, circadian parameters were only calculated after each
animal reached full resynchronization to the new LD schedule.
TABLE 1 | Summary of endogenous circadian parameters.
Parameter Sham Implanted p
Period τ (hours) 23.58 ± 0.07 23.92 ± 0.06 <0.01
α (hours) 13.43 ± 0.90 13.08 ± 0.75 >0.05
Activity in α % 85.13 ± 1.95 83.31 ± 1.89 >0.05
α/ρ 1.31 ± 0.28 1.17 ± 0.13 >0.05
V index 0.69 ± 0.08 0.66 ± 0.04 >0.05
IS index 0.44 ± 0.03 0.31 ± 0.02 <0.01
IV index 0.68 ± 0.08 1.04 ± 0.1 <0.05
Circadian rhythms of general activity in DD conditions. α, length of the subjective day; ρ,
length of the subjective night. See methods for details on V, IS, and IV index calculation.
Groups were compared by Student’s t-test.
FIGURE 1 | Hypothalamic LN229 glioblastoma cells implantation. (A) An example of a coronal slice of brain tissue where implanted cells resulted in tumor masses
compromising hypothalamic, ventricular and optic tract structures. (B) Another example showing a brain where the tumor affected the ipsilateral SCN and the optic
chiasm. (C) Tumor implantation resulted in vascularization of the tissue (yellow arrows). OC, Optic chiasm; 3V, third ventricle.
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FIGURE 2 | Hypothalamic glioma alters endogenous circadian timekeeping. (A) Representative actograms of control (sham) and implanted animals. Gray background
indicates lights-off. (B) Representative Sokolove-Bushell’s periodograms for sham and implanted animals showing the endogenous circadian period.
(C) Hypothalamic tumors increase the endogenous circadian period (23.92 ± 0.06 h, n = 9 and 23.58 ± 0.07, n = 6, for implanted and control (sham) animals,
respectively; **p < 0.01, Student’s t-test).
We first characterized whether animals were able to effectively
synchronize to the period imposed by an LD cycle. The period
observed under LD conditions did not vary between control
and implanted animals (Table 2), suggesting that hypothalamic
gliomas do not impair the clock in terms of following an
environmental cycle. Similarly, the amount of activity during
the day did not vary significantly between implanted and
control animals (Table 2). Next, when analyzing the rate
of reentrainment to an abrupt phase change of the LD
cycle, we found that implanted animals presented a slower
resynchronization to a 6-h advance, with an average PS50 of 3.96
± 0.21 days, as compared with the average PS50 of 2.78 ± 0.21
days for the control animals (Figures 4A,B and Table 2; extra
sum-of-squares F-test between PS50 for Implanted and Sham
mice, p < 0.001, n = 6 for control and implanted animals).This
result points to an impairment in the ability of the circadian
clock to adapt to changes in the Zeitgeber cycle in animals with
hypothalamic gliomas.
Phase angle is defined as the difference between the phase
of the circadian clock and the phase of its corresponding
Zeitgeber, and is important in setting the relation between
animal physiology and external environmental cues. We
analyzed if the phase angle between the clock and the LD cycle
was affected in animals bearing hypothalamic tumors. We found
that implanted animals showed a clear advance in the phase angle
between the activity onset and the time of light off, as compared
with the sham controls, which became more pronounced with
the progression of the tumor (Figure 4 and Table 2; repeated
measures Two-Way ANOVA followed by Holm-Sidak’s post-hoc
test for stage and treatment factors, p < 0.05 for the interaction.
Stage effects: p < 0.01 for implanted animals in PI vs. BI stage,
p< 0.01 for implanted animals in P-JL vs. PI stage, and p< 0.001
for implanted animals in P-JL vs. BI stage, p > 0.05 for all Sham
contrasts. Implantation effects: p< 0.001 for Sham vs. Implanted
animals in the P-JL stage, p > 0.05 for all other contrasts; n =
6 for control and implanted animals). This finding indicates a
persistent decline in the ability of the clock to set a proper phase
relation with environmental cue as the hypothalamic tumor
grows.
Finally, to characterize more subtle effects of hypothalamic
gliomas in the synchronization to LD cycles, we analyzed the
difference between the phase of general activity during the
first days of DD and compared it with the previous phase
during LD conditions. If an animal is properly synchronized
to the LD schedule, it can be expected that the phase in LD
conditions represents a good predictor of the phase once the
animal is transferred to constant DD conditions. We calculated
the individual phase difference between the average phase both
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FIGURE 3 | Hypothalamic gliomas affect endogenous period stability. (A) Representative actograms and their corresponding instantaneous period calculation of
control (sham) and implanted animals in constant darkness conditions. For instant periods, heatmaps plots refer to the significance of the endogenous period
calculated by wavelet analysis. The vertical axis represent the successive days of activity, with the same scale of the corresponding actograms. The horizontal axis
indicates the period in hours. The blue line shows the period of maximum significance across days. Black lines delimitate periods that are statistically significant
(Torrence and Compo, 1998). (B) Tumor-implanted animals showed higher fragmentation of locomotor activity rhythms, as well as less strength of coupling of the
activity to the τ that best describes the rhythms, although no effect was found by analysis of τ variability through wavelet-based computations (described by IV, IS,
and V indexes, respectively; Student’s t-test, *p < 0.05 for IV, **p < 0.01 for IS and p > 0.05 for V indexes, n = 6 for control and n = 9 for implanted animals).
in LD and in DD conditions and, surprisingly, we found that
sham animals presented a bigger phase difference than animals
carrying hypothalamic gliomas (Figure 5, p < 0.05, Student’s
t-test, n= 6 for controls, n= 9 for implanted mice).
DISCUSSION
The mammalian circadian clock is able to generate a coherent
output through a complex combination of molecular and
network mechanisms that can be synchronized by light inputs.
Since pathologies affecting hypothalamic function can disrupt
circadian timekeeping (Giustina and Braunstein, 2016), the
presence of anomalous cells, such as glia-derived tumor cells
could then modify circadian output clock, and be of relevance
in the diagnosis of this tumors. Therefore, we aimed to study the
effects of hypothalamic tumors on the circadian system, using an
animal model suitable both for human tumor implantation and
characterization of circadian parameters (Paladino et al., 2013).
The implantation of intracranial gliomas in the
suprachiasmatic hypothalamic region resulted in both alteration
of endogenous circadian timekeeping and in subtle changes
in the ability of the clock to synchronize to environmental
cycles. These phenomena should be interpreted in an integrative
way, since the synchronization process also depends on the
endogenous characteristics of the oscillator. Our results point
to three important alterations in animals carrying hypothalamic
gliomas: longer and unstable endogenous circadian period,
alteration in the phase relation between the clock and the
Zeitgeber, and a possible decrease of masking mechanisms.
The endogenous period of the circadian clock depends on
individual molecular oscillations that occur in each cell, as well
as on the coupling between different cells and regions of the
SCN (Evans, 2016). The pace of the molecular clock can be
modulated by the alteration of the transcription of clock genes,
or by post-transcriptional or post-translational modifications on
the products of the genes, affecting their stability or subcellular
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TABLE 2 | Summary of circadian parameters under LD conditions.
Parameter Group BI PI P-JL pa
Phase
angle ψ
(min)
Sham −15.88 ± 5.6 −1.49 ± 3.43 3 ± 8.16 >0.05
Implanted −16.67 ± 17.3 33.66 ± 7.64 92.33 ± 15.28 <0.05
pb >0.05 >0.05 <0.001
LD period
(h)
Sham 24.08 ± 0.03 24.05 ± 0.02 24.05 ± 0.04 >0.05
Implanted 23.99 ± 0.01 24.06 ± 0.02 24.06 ± 0.04 >0.05
pb >0.05 >0.05 >0.05
Diurnal
activity %
Sham 24.54 ± 1.91 26.73 ± 2.6 33.46 ± 2 >0.05
Implanted 34.64 ± 2.22 34.00 ± 2.40 29.23 ± 2.98 >0.05
pb >0.05 >0.05 >0.05
P50 Sham 2.78 ± 0.21
Implanted 3.96 ± 0.21
pc <0.001
For phase angle, data was analyzed by repeated measures two-way ANOVA, with p <
0.05 for the interaction effect. Effects of treatment (tumor implantation) and stage were
assessed by Holm-Sidak’s multiple comparisons test. For LD period and diurnal activity
percentage, data was analyzed by repeated measures two-way ANOVA with p > 0.05 for
treatment, stage and interaction effects. For reentrainment rate, data was adjusted to a
sigmoid dose-response curve with variable slope and differences between best-fit PS50
for Sham and Implanted groups were analyzed by extra sum-of-squares F-test.
aPost-test for stage factor.
bPost-test for treatment factor.
cStudent’s t-test.
localization (Lowrey and Takahashi, 2011). Gliomas impose
a deep alteration on the environment where they develop,
secreting a variety of factors, increasing the vascularization, and
remodeling the extracellular matrix, among others. Within the
molecules that are increased in the tumor microenvironment,
glutamate and immune factors such as TNF-α, IL-1α, and CCL2
should be taken into special consideration. Glioma cells increases
extracellular glutamate levels both by means of glutamate
release and by silencing of EAAT genes; indeed, increases in
glutamate levels are proposed to favor neuronal death through
excitotoxicity generating a physical niche for tumor growth
(Watkins and Sontheimer, 2012). Glutamate is released in the
SCN in response to light, activating a signaling cascade that
induces clock gene expression (Golombek and Rosenstein, 2010).
High glutamate levels in DD conditions could modulate clock
gene expression through signaling pathways normally activated
by light, inducing the alterations in τ found in implanted animals.
Regarding the alteration of immune-related signaling molecules,
TNF-α, IL-1β, and CCL2 have been shown to modulate the
circadian clock, at the SCN level (Leone et al., 2012; Duhart
et al., 2016). These, and/or other cytokines/chemokines, which
are increased in the tumor microenvironment (Christofides et al.,
2015; Vakilian et al., 2017) could modulate either the pace of the
molecular clock or the coupling among different neurons.
Our results also showed that the proper phase relation
between the oscillator outputs and the environmental cues
is impaired in animals carrying hypothalamic gliomas, as
evidenced by the increased phase angle between general activity
rhythm onset and the time of lights-off. The alterations in the
characteristics of the clock synchronization to LD cycles could
be affected by the same mechanisms that lead to changes in
endogenous pacemaking, which could also alter the shape and
amplitude of the phase response curve (i.e., the differential effect
of light on the phase of circadian rhythms according to the
time of stimulation). In particular, abnormal glutamate levels
in the SCN could affect synchronization to light, since this
neurotransmitter is normally released preferentially during the
day in this region, and induces phases adjustments if released
during the night (Gillette and Mitchell, 2002). Also, TGF-α is
elevated in the glioma microenvironment (Schlegel et al., 1990),
and this molecule has been described to mediate the relation
between the SCN and different clock outputs (Kramer et al.,
2001). A dysregulation of TGF-α at the SCN level could thus lead
to alterations in the coupling between the clock and the control
of activity output.
Circadian entrainment was also evaluated by comparing the
differences between the phase of general activity in LD and in
the first days of DD conditions (Figure 5). If the oscillator is
truly synchronized to the LD cycle, the phase during the first
days in DD is predicted to be similar to the previous phase
under LD. We found that control animals showed a bigger
difference between the phase in LD and in DD conditions, which
could be interpreted as a signal of a masking phenomenon in
which the output (general activity) is directly modulated by the
Zeitgeber. Masking might serve as a fine adjustment mechanism
in the synchronization process; although the specific anatomical
structure sustaining this phenomenon has not been identified.
It has been has been suggested that masking might rely on
TGF-α acting on the ventral subparaventricular zone (vSPZ, a
region adjacent to the SCN) of the hypothalamus (Kramer et al.,
2001). As stated before, TGF-α has been detected in human
glioblastomas, correlating with the proliferative aggressiveness of
the tumors (von Bossanyi et al., 1998). Alteration of this signal
in the hypothalamic tumor microenvironment could impair the
mechanism by which masking modulates activity rhythms, and
this could be evidenced in the smaller phase difference between
LD and DD conditions in animal bearing hypothalamic gliomas.
It should also be noted that gliomas have a strong influence
in the physiology of the normal glial cells compromised in the
tumor microenvironment. Astrocytes have recently been shown
to be active players in setting the endogenous timekeeping of
the circadian clock (Brancaccio et al., 2017; Tso et al., 2017).
In addition, activation of these cells by immune factors induces
changes in their molecular clock and, in response, astrocytes
can modulate clock gene expression in the SCN (Duhart et al.,
2013a). Gliomas have been shown to alter the coupling between
astrocytes and the vasculature (Watkins et al., 2014), and to
render astrocytes in an activated state (Lee et al., 2011; Raore
et al., 2011). These or other changes in astroglial functioning
could have an impact in the circadian clock, contributing to the
effects seen in animals bearing hypothalamic tumors.
In summary, the glioma microenvironment greatly alters
the levels of different molecules that can modulate clock
gene expression, activate the photic synchronization pathway,
and/or mediate the mechanisms underlying masking to light.
These phenomena were evidenced in our murine model of
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FIGURE 4 | Synchronization to LD cycles is altered by hypothalamic gliomas. (A) Representative actograms of control (sham) and implanted animals under LD cycles
and a simulated Jet-lag protocol (6-h advance in the LD cycle). (B) Tumor implantation resulted in slower resynchronization to abrupt shifts in the LD cycle. The phase
of activity onset, in minutes, is plotted for each day before and after the Jet-lag protocol. Gray background indicates the time of lights-off. A continuous line indicates
the adjusted sigmoid dose-response curve with variable slope for each group. The dashed gray line indicates the 50% phase resynchronization, and vertical dashed
lines indicate the PS50 for each group. Control animals showed shorter PS50 adjusted value, indicating faster resynchronization (extra sum-of-squares F-test,
***p < 0.001, n = 6 for control and implanted animals). (C) Representative waveforms of general activity of control (sham) and implanted animals in three different
stages of the protocol (BI, Before implantation; AI, After implantation; P-JL, Post Jet Lag). (D) Tumor-implanted animals exhibited an advanced phase angle between
the circadian rhythm in general activity and the LD cycle. (repeated measures Two-Way ANOVA followed by Holm-Sidak’s post-hoc test for stage and treatment-tumor
implantation-factors, p < 0.05 for the interaction. Stage effects: **p < 0.01 for implanted animals in PI vs. BI stage, **p < 0.01 for implanted animals in P-JL vs. PI
stage, and ***p < 0.001 for implanted animals in P-JL vs. BI stage, p > 0.05 for all Sham contrasts. Implantation effects: ***p < 0.001 for Sham vs. Implanted animals
in the P-JL stage, p > 0.05 for all other contrasts; n = 6 for control and implanted animals).
hypothalamic gliomas. While the effects of gliomas located
in the hypothalamic/optic tract region on circadian rhythms
have not been extensively analyzed in patients yet, one report
from an hypothalamic astrocytoma case compromising the
SCN region described, among other symptoms, an inversion
in the wake-sleep cycle (Haugh and Markesbery, 1983). Also,
pediatric patients carrying craniopharyngiomas, which usually
compromises the optic tract and produce injury in the
hypothalamus, present daytime sleepiness and alterations in the
melatonin secretion rhythm (Müller et al., 2002). Recently, adult
patients suffering from craniopharyngiomas were also described
to present impaired 24 h sleep-wake and temperature circadian
rhythms (Foschi et al., 2017). It has been previously reported that
sleep disturbances are related to high-grade glioma progression
(Yavas et al., 2012), although the availability of data regarding the
effects of solid brain tumors on sleep/wake cycle is still limited
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FIGURE 5 | Hypothalamic gliomas alter the relation between clock outputs and LD cycles. (A) Rayleigh analysis of average phase differences between LD and DD
conditions for individual animals. (B) Tumor implantation resulted in a smaller difference between the phase of general activity in LD and DD conditions (*p < 0.05
Student’s t-test, n = 6 for controls, n = 9 for implanted).
(Armstrong et al., 2017). Our work shows that hypothalamic
gliomas can alter the endogenous properties of the clock, as well
as the relation between the pacemaker, environment and output
variables, suggesting that assessing simple circadian parameters,
such as body core temperature, as well as sleep/wake cycle
analysis, might be of importance during the clinical assessment
and track of this disease. Further research in the characterization
of the influence of hypothalamic/optic tract tumors on circadian
rhythms could also be of importance in developing new factors
or parameters that help both diagnosis and monitoring the
progression of these diseases.
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